Literature DB >> 993641

A new look at the plasma disappearance of sulfobromophthalein (BSP): correlation with the BSP transport maximum and the hepatic plasma flow in man.

W Häcki, J Bircher, R Preisig.   

Abstract

In order to improve the clinical usefulness of the plasma disappearance curve of sulfobromophthalein (BSP), its components were analyzed in 26 control subjects, in 28 patients with cirrhosis, and in 13 cases of miscellaneous liver abnormalities. The uncorrected initial disappearance rate (ki) was found to discriminate best between the control and the patient groups. The second exponential component (k2) was linearly correlated with the transport maximum (Tm) on a double logarithmic plot, but appeared to be independent of the estimated hepatic plasma flow (EHPF). An interpretation of this relationship was possible, when based on a model having saturation kinetics for biliary excretion. The first exponential component (ki) appeared primarily determined by hepatic perfusion. These relationships may contribute to a better understanding and more rational use of dye excretion tests as measures of hepatic function. The data also add to our knowledge about the nature of the excretory defect in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993641

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  14 in total

Review 1.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

2.  No association between Gilbert's syndrome, the ABO blood groups and the haptoglobin phenotypes.

Authors:  R Platzer; J Bircher
Journal:  Experientia       Date:  1977-09-15

3.  Maximal biliary transport of sulfobromophthalein in patients with a T-tube placed in the common bile duct.

Authors:  M A Serra; A Caballero; J A Del Olmo; L Aparisi; M S Gilabert; F Rodríguez; A Escudero; A Wassel; J Ferrando; G Reig; J M Rodrigo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Apr-Jun       Impact factor: 2.441

4.  Mesocaval and distal splenorenal shunts: effect on hepatic function, hepatic hemodynamics, and portal systemic encephalopathy.

Authors:  R Herz; H J Halbfass; M Rössle; D Waldmann; W Gerok
Journal:  Klin Wochenschr       Date:  1985-05-02

5.  New results on saturation phenomena in BSP metabolism: the role of free and conjugated BSP.

Authors:  M Milanese; G Molino; F Cappelletti
Journal:  Med Biol Eng Comput       Date:  1981-11       Impact factor: 2.602

6.  Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.

Authors:  J Cotting; M J Lentze; J Reichen
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

7.  Chemotherapy of larval echinococcosis with mebendazole: microsomal liver function and cholestasis as determinants of plasma drug level.

Authors:  F Witassek; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver.

Authors:  R Herz; M Rössle; T Bonzel; E Keller; W Gerok
Journal:  Klin Wochenschr       Date:  1984-08-16

9.  Chronic administration of cyclosporin A induces a decrease in hepatic excretory function in man.

Authors:  J F Cadranel; S Erlinger; M Desruenne; J Luciani; F Lunel; P Grippon; A Cabrol; P Opolon
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

10.  Nicotinic acid test in the diagnosis of Gilbert's syndrome: correlation with bilirubin clearance.

Authors:  W Röllinghoff; G Paumgartner; R Preisig
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.